Global Anti - Neoplastic Agents Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
    1.1 Anti - Neoplastic Agents Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Anti - Neoplastic Agents Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Chemotherapy
        1.2.3 Targeted Therapy
        1.2.4 Immunotherapy
        1.2.5 Hormonal Therapy(Biologic Therapy)
        1.2.6 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Anti - Neoplastic Agents Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Respiratory/Lung Cancer
        1.3.7 Other Cancers
    1.4 Global Anti - Neoplastic Agents Market Size & Forecast
        1.4.1 Global Anti - Neoplastic Agents Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Anti - Neoplastic Agents Sales in Volume (2017-2028)
        1.4.3 Global Anti - Neoplastic Agents Price (2017-2028) 
    1.5 Global Anti - Neoplastic Agents Production Capacity Analysis
        1.5.1 Global Anti - Neoplastic Agents Total Production Capacity (2017-2028)
        1.5.2 Global Anti - Neoplastic Agents Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Anti - Neoplastic Agents Market Drivers
        1.6.2 Anti - Neoplastic Agents Market Restraints
        1.6.3 Anti - Neoplastic Agents Trends Analysis
2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Anti - Neoplastic Agents Product and Services
        2.1.4 Roche Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Novartis
        2.2.1 Novartis Details
        2.2.2 Novartis Major Business
        2.2.3 Novartis Anti - Neoplastic Agents Product and Services
        2.2.4 Novartis Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Celgene
        2.3.1 Celgene Details
        2.3.2 Celgene Major Business
        2.3.3 Celgene Anti - Neoplastic Agents Product and Services
        2.3.4 Celgene Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Bristol-Myers Squibb
        2.4.1 Bristol-Myers Squibb Details
        2.4.2 Bristol-Myers Squibb Major Business
        2.4.3 Bristol-Myers Squibb Anti - Neoplastic Agents Product and Services
        2.4.4 Bristol-Myers Squibb Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Amgen
        2.5.1 Amgen Details
        2.5.2 Amgen Major Business
        2.5.3 Amgen Anti - Neoplastic Agents Product and Services
        2.5.4 Amgen Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Johnson & Johnson
        2.6.1 Johnson & Johnson Details
        2.6.2 Johnson & Johnson Major Business
        2.6.3 Johnson & Johnson Anti - Neoplastic Agents Product and Services
        2.6.4 Johnson & Johnson Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Anti - Neoplastic Agents Product and Services
        2.7.4 Pfizer Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Takeda
        2.8.1 Takeda Details
        2.8.2 Takeda Major Business
        2.8.3 Takeda Anti - Neoplastic Agents Product and Services
        2.8.4 Takeda Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Eli Lilly
        2.9.1 Eli Lilly Details
        2.9.2 Eli Lilly Major Business
        2.9.3 Eli Lilly Anti - Neoplastic Agents Product and Services
        2.9.4 Eli Lilly Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 AstraZeneca
        2.10.1 AstraZeneca Details
        2.10.2 AstraZeneca Major Business
        2.10.3 AstraZeneca Anti - Neoplastic Agents Product and Services
        2.10.4 AstraZeneca Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Astellas
        2.11.1 Astellas Details
        2.11.2 Astellas Major Business
        2.11.3 Astellas Anti - Neoplastic Agents Product and Services
        2.11.4 Astellas Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Merck & Co.
        2.12.1 Merck & Co. Details
        2.12.2 Merck & Co. Major Business
        2.12.3 Merck & Co. Anti - Neoplastic Agents Product and Services
        2.12.4 Merck & Co. Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Sanofi
        2.13.1 Sanofi Details
        2.13.2 Sanofi Major Business
        2.13.3 Sanofi Anti - Neoplastic Agents Product and Services
        2.13.4 Sanofi Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Bayer
        2.14.1 Bayer Details
        2.14.2 Bayer Major Business
        2.14.3 Bayer Anti - Neoplastic Agents Product and Services
        2.14.4 Bayer Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Biogen Idec
        2.15.1 Biogen Idec Details
        2.15.2 Biogen Idec Major Business
        2.15.3 Biogen Idec Anti - Neoplastic Agents Product and Services
        2.15.4 Biogen Idec Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Eisai
        2.16.1 Eisai Details
        2.16.2 Eisai Major Business
        2.16.3 Eisai Anti - Neoplastic Agents Product and Services
        2.16.4 Eisai Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Teva
        2.17.1 Teva Details
        2.17.2 Teva Major Business
        2.17.3 Teva Anti - Neoplastic Agents Product and Services
        2.17.4 Teva Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Otsuka
        2.18.1 Otsuka Details
        2.18.2 Otsuka Major Business
        2.18.3 Otsuka Anti - Neoplastic Agents Product and Services
        2.18.4 Otsuka Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.19 Merck KGaA
        2.19.1 Merck KGaA Details
        2.19.2 Merck KGaA Major Business
        2.19.3 Merck KGaA Anti - Neoplastic Agents Product and Services
        2.19.4 Merck KGaA Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.20 Ipsen
        2.20.1 Ipsen Details
        2.20.2 Ipsen Major Business
        2.20.3 Ipsen Anti - Neoplastic Agents Product and Services
        2.20.4 Ipsen Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.21 AbbVie
        2.21.1 AbbVie Details
        2.21.2 AbbVie Major Business
        2.21.3 AbbVie Anti - Neoplastic Agents Product and Services
        2.21.4 AbbVie Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.22 Gilead Sciences
        2.22.1 Gilead Sciences Details
        2.22.2 Gilead Sciences Major Business
        2.22.3 Gilead Sciences Anti - Neoplastic Agents Product and Services
        2.22.4 Gilead Sciences Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti - Neoplastic Agents Breakdown Data by Manufacturer
    3.1 Global Anti - Neoplastic Agents Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Anti - Neoplastic Agents Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Anti - Neoplastic Agents
    3.4 Market Concentration Rate
        3.4.1 Top 3 Anti - Neoplastic Agents Manufacturer Market Share in 2021
        3.4.2 Top 6 Anti - Neoplastic Agents Manufacturer Market Share in 2021
    3.5 Global Anti - Neoplastic Agents Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Anti - Neoplastic Agents Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Anti - Neoplastic Agents Market Size by Region
        4.1.1 Global Anti - Neoplastic Agents Sales in Volume by Region (2017-2028)
        4.1.2 Global Anti - Neoplastic Agents Revenue by Region (2017-2028)
    4.2 North America Anti - Neoplastic Agents Revenue (2017-2028)
    4.3 Europe Anti - Neoplastic Agents Revenue (2017-2028)
    4.4 Asia-Pacific Anti - Neoplastic Agents Revenue (2017-2028)
    4.5 South America Anti - Neoplastic Agents Revenue (2017-2028)
    4.6 Middle East and Africa Anti - Neoplastic Agents Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Anti - Neoplastic Agents Sales in Volume by Type (2017-2028)
    5.2 Global Anti - Neoplastic Agents Revenue by Type (2017-2028)
    5.3 Global Anti - Neoplastic Agents Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Anti - Neoplastic Agents Sales in Volume by Application (2017-2028)
    6.2 Global Anti - Neoplastic Agents Revenue by Application (2017-2028)
    6.3 Global Anti - Neoplastic Agents Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Anti - Neoplastic Agents Sales by Type (2017-2028)
    7.2 North America Anti - Neoplastic Agents Sales by Application (2017-2028)
    7.3 North America Anti - Neoplastic Agents Market Size by Country
        7.3.1 North America Anti - Neoplastic Agents Sales in Volume by Country (2017-2028)
        7.3.2 North America Anti - Neoplastic Agents Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Anti - Neoplastic Agents Sales by Type (2017-2028)
    8.2 Europe Anti - Neoplastic Agents Sales by Application (2017-2028)
    8.3 Europe Anti - Neoplastic Agents Market Size by Country
        8.3.1 Europe Anti - Neoplastic Agents Sales in Volume by Country (2017-2028)
        8.3.2 Europe Anti - Neoplastic Agents Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Anti - Neoplastic Agents Sales by Type (2017-2028)
    9.2 Asia-Pacific Anti - Neoplastic Agents Sales by Application (2017-2028)
    9.3 Asia-Pacific Anti - Neoplastic Agents Market Size by Region
        9.3.1 Asia-Pacific Anti - Neoplastic Agents Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Anti - Neoplastic Agents Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Anti - Neoplastic Agents Sales by Type (2017-2028)
    10.2 South America Anti - Neoplastic Agents Sales by Application (2017-2028)
    10.3 South America Anti - Neoplastic Agents Market Size by Country
        10.3.1 South America Anti - Neoplastic Agents Sales in Volume by Country (2017-2028)
        10.3.2 South America Anti - Neoplastic Agents Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Anti - Neoplastic Agents Sales by Type (2017-2028)
    11.2 Middle East & Africa Anti - Neoplastic Agents Sales by Application (2017-2028)
    11.3 Middle East & Africa Anti - Neoplastic Agents Market Size by Country
        11.3.1 Middle East & Africa Anti - Neoplastic Agents Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Anti - Neoplastic Agents Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Anti - Neoplastic Agents and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Anti - Neoplastic Agents
    12.3 Anti - Neoplastic Agents Production Process
    12.4 Anti - Neoplastic Agents Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Anti - Neoplastic Agents Typical Distributors
    13.3 Anti - Neoplastic Agents Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer